CLDN2 and Cowden disease: Therefore, lubiprostone inhibition of claudin-2 is consistent with an improvement in TER, and modulation of one or more claudin family members may also be a contributory factor to the observed improvement in TER in lubiprostone-treated CD biopsies in the present study.